The Academy of Medical Sciences, Vietnam approaches clinical research through scientifically justified protocols, independent ethics oversight, participant protection, appropriate operations, data-quality controls, statistical analysis, and transparent reporting.

Clinical Research

Clinical evidence can strengthen responsible marketing and product positioning when communications accurately reflect the study design, population, endpoints, effect size, uncertainty, limitations, and actual results. Evidence should never be converted into broader claims than the data and regulations support.

Clinical Research

Clinical data may be included in investor or IPO communications when material information is presented accurately and consistently with legal disclosure obligations. Evidence should not be exaggerated, and limitations, uncertainty, study status, and unfavorable findings may be material.

Clinical data may be included in investor or IPO communications when material information is presented accurately and consistently with legal disclosure obligations. Evidence should not be exaggerated, and limitations, uncertainty, study status, and unfavorable findings may be material.

Clinical Research

1. Clinical evidence can strengthen responsible marketing and product positioning when communications accurately reflect the study design, population, endpoints, effect size, uncertainty, limitations, and actual results. Evidence should never be converted into broader claims than the data and regulations support.
2. Clinical evidence can strengthen responsible marketing and product positioning when communications accurately reflect the study design, population, endpoints, effect size, uncertainty, limitations, and actual results. Evidence should never be converted into broader claims than the data and regulations support.
3. Clinical evidence can strengthen responsible marketing and product positioning when communications accurately reflect the study design, population, endpoints, effect size, uncertainty, limitations, and actual results. Evidence should never be converted into broader claims than the data and regulations support.
4. Clinical evidence can strengthen responsible marketing and product positioning when communications accurately reflect the study design, population, endpoints, effect size, uncertainty, limitations, and actual results. Evidence should never be converted into broader claims than the data and regulations support.

Reporting

• Clinical data may be included in investor or IPO communications when material information is presented accurately and consistently with legal disclosure obligations. Evidence should not be exaggerated, and limitations, uncertainty, study status, and unfavorable findings may be material.
• Clinical evidence can strengthen responsible marketing and product positioning when communications accurately reflect the study design, population, endpoints, effect size, uncertainty, limitations, and actual results. Evidence should never be converted into broader claims than the data and regulations support.
• Clinical data may be included in investor or IPO communications when material information is presented accurately and consistently with legal disclosure obligations. Evidence should not be exaggerated, and limitations, uncertainty, study status, and unfavorable findings may be material.
• Clinical data may be included in investor or IPO communications when material information is presented accurately and consistently with legal disclosure obligations. Evidence should not be exaggerated, and limitations, uncertainty, study status, and unfavorable findings may be material.

Clinical Research

The Academy of Medical Sciences, Vietnam approaches clinical research through scientifically justified protocols, independent ethics oversight, participant protection, appropriate operations, data-quality controls, statistical analysis, and transparent reporting.

The Academy of Medical Sciences, Vietnam approaches clinical research through scientifically justified protocols, independent ethics oversight, participant protection, appropriate operations, data-quality controls, statistical analysis, and transparent reporting.

Clinical data may be included in investor or IPO communications when material information is presented accurately and consistently with legal disclosure obligations. Evidence should not be exaggerated, and limitations, uncertainty, study status, and unfavorable findings may be material.

Clinical data may be included in investor or IPO communications when material information is presented accurately and consistently with legal disclosure obligations. Evidence should not be exaggerated, and limitations, uncertainty, study status, and unfavorable findings may be material.

The Academy of Medical Sciences, Vietnam approaches clinical research through scientifically justified protocols, independent ethics oversight, participant protection, appropriate operations, data-quality controls, statistical analysis, and transparent reporting.